Reports
Showing 73–84 of 287 results
-
Phase IV CRO Benchmarking (12th Ed.)
$5,400.00 – $10,800.00 -
Phase I CRO Benchmarking (12th Ed.)
$5,400.00 – $10,800.00 -
Phase II/III CRO Benchmarking (12th Ed.)
$5,400.00 – $10,800.00 -
Small Molecule API CDMO Benchmarking for Small & New Pharma
$3,450.00 – $6,900.00 -
Biologic Drug Product CDMO Benchmarking for Small & New Pharma
$3,450.00 – $6,900.00 -
Small Molecule Drug Product CDMO Benchmarking (3rd Ed.)
$5,400.00 – $10,800.00 -
Biologic API CDMO Benchmarking (5th Ed.)
$5,400.00 – $10,800.00 -
Small Molecule API CDMO Benchmarking (5th Ed.)
$5,400.00 – $10,800.00 -
Biologic Drug Product CDMO Benchmarking (3rd Ed.)
$5,400.00 – $10,800.00 -
Bioanalytical Lab Benchmarking (4th Ed.)
$4,460.00 – $8,920.00 -
Pharmacovigilance Benchmarking & Market Dynamics (2nd Ed.)
$4,460.00 – $8,920.00 -
eTMF Benchmarking & Market Dynamics (2nd Ed.)
$4,160.00 – $8,320.00
